Review and discussion of tubular biomarkers in the diagnosis and management of diabetic nephropathy. - sprookjes - yvandenbroek - TriplyDB

Review and discussion of tubular biomarkers in the diagnosis and management of diabetic nephropathy.

Review and discussion of tubular biomarkers in the diagnosis and management of diabetic nephropathy.

http://www.wikidata.org/entity/Q38053941

about

Economic impact of combining metformin with dipeptidyl peptidase-4 inhibitors in diabetic patients with renal impairment in spanish patients.Urinary Cyclophilin A as a New Marker for Diabetic Nephropathy: A Cross-Sectional Analysis of Diabetes Mellitus Development of a Functional Glomerulus at the Organ Level on a Chip to Mimic Hypertensive Nephropathy.Low protein diet inhibits uric acid synthesis and attenuates renal damage in streptozotocin-induced diabetic rats.Nonalbuminuric proteinuria as a biomarker for tubular damage in early development of nephropathy with type 2 diabetic patients.Adipokine zinc-alpha-2-glycoprotein as a novel urinary biomarker presents earlier than microalbuminuria in diabetic nephropathy Andrographolide suppresses high glucose-induced fibronectin expression in mesangial cells via inhibiting the AP-1 pathway.A more tubulocentric view of diabetic kidney disease.Routine kidney variables, glomerular filtration rate and urinary cystatin C in cats with diabetes mellitus, cats with chronic kidney disease and healthy cats.Biomarkers of diabetic nephropathy: A 2017 update.Urinary DcR2 is a novel biomarker for tubulointerstitial injury in patients with diabetic nephropathy.Tubulointerstitial Biomarkers for Diabetic Nephropathy.Assessment of Vitamin D-Binding Protein and Early Prediction of Nephropathy in Type 2 Saudi Diabetic Patients.

P2860

Q35126858-EC0F5CF8-D423-420A-A60B-478B4A8C411D Q36207045-EF2D674D-1A2C-4D19-849D-119CBEE1892F Q37202510-C1FD7098-B777-47DB-A2F7-18E2E2924D09 Q37686722-B375D3B4-19AB-4C26-BC7D-DCC8847A0C0D Q42227812-A5658759-C6CD-466D-BBE7-167B83B05103 Q42352782-F5965701-7017-4DF8-9DFB-F99AA930EAB6 Q43928331-BD1D4264-4A72-4A93-9C4B-05DA261BCE4F Q47108081-53F2EA6A-5027-4076-97E8-E767632A342D Q49034688-430F0E70-E155-405D-883A-683B9786F935 Q49686004-79C1E883-D82B-4F5D-AF5F-2C88302FA124 Q51081666-00E04419-4934-454B-A495-C177C3FEC73F Q52632440-BA1E928D-AD69-4676-96B4-B15228869AC4 Q55003733-16F9FBC8-A0A1-4216-9FBB-0B9A0108B8F1

P2860

Review and discussion of tubular biomarkers in the diagnosis and management of diabetic nephropathy.

http://www.wikidata.org/entity/Q38053941

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Review and discussion of tubul ...... ement of diabetic nephropathy.

@en

type

label

Review and discussion of tubul ...... ement of diabetic nephropathy.

@en

prefLabel

Review and discussion of tubul ...... ement of diabetic nephropathy.

@en

P1433

Q38053941-9154293D-AEC5-4EEA-9620-2F3A7759D6DA

P1476

Q38053941-225984FF-5625-4FFD-94D1-270E063B02A6

P2093

Q38053941-67C9167D-7A59-4367-8618-8EC11518D775

Q38053941-D133A4D2-E79A-47CA-B82C-C79094F43393

P2860

Q38053941-017DC3AC-C47D-425F-A66C-B22BDA53729A

Q38053941-028255D8-9000-46F5-8F1A-365CED899922

Q38053941-04533C23-FCCF-4447-B6E3-D7A8000E2410

Q38053941-0616DEA6-E3E6-4CD3-852E-CE46E51534EE

Q38053941-11C146CB-C2DF-40F0-A2BC-7D925461C762

Q38053941-186E812B-E9B1-4A67-9AA9-E61EFBBDE822

Q38053941-1C58CA89-3477-4936-8ECD-CF82345A9268

Q38053941-1CE31ECE-0B7C-40A6-91C3-4D6D21812633

Q38053941-21B41234-0D4A-4289-AB3D-D4BA2A490B70

Q38053941-27F8BE9F-2602-4C4A-99B9-5F1CB9D17EFC

P2888

Q38053941-931FAA08-16E3-4D10-818F-583AE3A20D0A

P304

Q38053941-C219EF11-DD1B-4912-9239-FEDBB70003F4

P31

Q38053941-CF3F5FA3-2557-4026-9B8F-CEAF75066F8A

P356

Q38053941-9EDDB025-6A9E-4A7D-87FC-2262A2C06000

P433

Q38053941-1200A42B-CA89-48F8-A73D-FF8CF2A6821F

P478

Q38053941-C800FFEA-38CE-47F1-B571-035A415FBA6B

P577

Q38053941-4D70C8EC-4442-411B-B8B6-B9A489380D0C

P698

Q38053941-914C6159-CC04-4E91-B76D-36C28B209277

P921

Q38053941-BA5E499D-52E7-4054-9E53-127069818483

P932

Q38053941-FE97F12C-E176-4D3D-A46D-B9EB148A8E04

P356

S12020-012-9820-Y

P1433

P1476

Review and discussion of tubul ...... ement of diabetic nephropathy.

@en

P2093

Gianfranco Tramonti

http://www.w3.org/2001/XMLSchema#string

Yashpal S Kanwar

http://www.w3.org/2001/XMLSchema#string

P2860

Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markers

Shedding of kidney injury molecule-1, a putative adhesion protein involved in renal regeneration

Tubular kidney injury molecule-1 in protein-overload nephropathy

Multicentric validation of proteomic biomarkers in urine specific for diabetic nephropathy

Urinary fatty acid–binding protein as a new clinical marker of the progression of chronic renal disease

Urinary and renal interstitial concentrations of TNF-alpha increase prior to the rise in albuminuria in diabetic rats.

Proteomic analysis of urinary protein markers for accurate prediction of diabetic kidney disorder.

Characterization of diabetic nephropathy by urinary proteomic analysis: identification of a processed ubiquitin form as a differentially excreted protein in diabetic nephropathy patients.

Increased urinary excretion of orosomucoid is a risk predictor of diabetic nephropathy.

Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.

P2888

s12020-012-9820-y

P304

494-503

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12020-012-9820-Y

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

43

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23086402

http://www.w3.org/2001/XMLSchema#string

P921

P932

3670820

http://www.w3.org/2001/XMLSchema#string